Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors:: distribution and involvement in the secretion of Podarcis sicula adrenal gland

被引:9
|
作者
Valiante, Salvatore [1 ]
Prisco, Marina [1 ]
Sciarrillol, Rosaria [2 ]
De Falco, Maria [1 ]
Capaldo, Anna [1 ]
Gay, Flarninia [1 ]
Andreuccetti, Piero [1 ]
Laforgia, Vincenza [1 ]
Varano, Lorenzo [1 ]
机构
[1] Univ Naples Federico II, Dipartimento Sci Biol, Sez Biol Evolut & Comparata, I-80134 Naples, Italy
[2] Univ Sannio, Dipartimento Sci Biol & Ambientali, Benevento, Italy
关键词
D O I
10.1677/JOE-07-0127
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) are regulatory neuro-peptides of the hypothalamus-hypophyseal-adrenal axis, acting via the common receptors VPAC(1) and VPAC(2) and the selective PACAP receptor PAC(1). In the adrenal glands of the Italian wall lizard, Podarcis sicula, the presence of VIP in chromaffin cells, and the VIP-stimulated release of catecholamine and aldosterone in vivo, was previously shown. To examine the localization of both peptides and receptors and their mRNAs in the adrenal gland of P. sicula, immunohistochemistry and in situ hybridization were performed: PACAP and its mRNA were detected in chromaffin cells, VPAC(1) was found associated with steroidogenic tissue, VPAC2 and PAC(1) with chromaffin tissue. Using far western blot' technique, we showed the presence of specific binding sites for VIP/PACAP in the adrenal glands of the lizard. The effects of both VIP and PACAP on the adrenal cells of the lizard were examined in vitro in adrenal cell co-cultures: both VIP and PACAP enhanced catecholamine, corticosterone and aldosterone release from adrenal cell co-culture in a time- and dose-dependent manner. The catecholamine release was inhibited by PAC(1) antagonist and in VPAC(2) immunoneutralized adrenal cells. The effects of VIP and PACAP on aldosterone secretion were counteracted by VPAC(1) antagonist administration in vitro. Corticosterone secretion elicited by VIP was not blocked by VPAC(1) antagonist, while the PACAP-induced release of corticosterone was blocked by the antagonist. Overall, our investigations indicate that these neuropeptides of the secretin superfamily can act not only as neurotransmitters but also as autocrine and paracrine regulators on chromaffin and cortical cells, being important mediators of the non-cholinergic system in the lizard adrenal gland.
引用
收藏
页码:291 / 303
页数:13
相关论文
共 50 条
  • [1] Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP/vasoactive intestinal polypeptide receptors: Actions on the anterior pituitary gland
    Rawlings, SR
    Hezareh, M
    ENDOCRINE REVIEWS, 1996, 17 (01) : 4 - 29
  • [2] Expression and function of vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide, and their receptors in the human adrenal gland
    Mazzocchi, G
    Malendowicz, LK
    Rebuffat, P
    Gottardo, L
    Nussdorfer, GG
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (06): : 2575 - 2580
  • [3] Pituitary adenylate cyclase-activating polypeptide receptors in the fetal human adrenal gland
    Yon, L
    Breault, L
    Contesse, V
    Bellancourt, G
    Delarue, C
    Fournier, A
    Lehoux, JG
    Gallo-Payet, N
    Vaudry, H
    VIP, PACAP, AND RELATED PEPTIDES: THIRD INTERNATIONAL SYMPOSIUM, 1998, 865 : 416 - 419
  • [4] Pharmacological, molecular and functional characterization of vasoactive intestinal polypeptide pituitary adenylate cyclase-activating polypeptide receptors in the rat pineal gland
    Simonneaux, V
    Kienlen-Campard, P
    Loeffler, JP
    Basille, M
    Gonzalez, BJ
    Vaudry, H
    Robberecht, P
    Pevet, P
    NEUROSCIENCE, 1998, 85 (03) : 887 - 896
  • [5] Special issue - Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide - Introduction
    Vaudry, Hubert
    PEPTIDES, 2007, 28 (09)
  • [6] Comparative distribution of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide immunoreactivity in the chicken forebrain
    Peeters, K
    Berghman, LR
    Vandesande, F
    TRENDS IN COMPARATIVE ENDOCRINOLOGY AND NEUROBIOLOGY: FROM MOLECULAR TO INTEGRATIVE BIOLOGY, 1998, 839 : 417 - 419
  • [7] POSSIBLE INVOLVEMENT OF VASOACTIVE INTESTINAL POLYPEPTIDE IN THE CENTRAL STIMULATING ACTION OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE ON PROLACTIN SECRETION IN THE RAT
    YAMAUCHI, K
    MURAKAMI, Y
    NISHIKI, M
    TANAKA, J
    KOSHIMURA, K
    KATO, Y
    NEUROSCIENCE LETTERS, 1995, 189 (02) : 131 - 134
  • [8] RECEPTORS FOR PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE - COMPARISON WITH VASOACTIVE-INTESTINAL-PEPTIDE RECEPTORS
    ARIMURA, A
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1992, 3 (08): : 288 - 294
  • [9] Heterogeneity of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide receptors in rat intrinsic cardiac neurons
    DeHaven, WI
    Cuevas, J
    NEUROSCIENCE LETTERS, 2002, 328 (01) : 45 - 49
  • [10] PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE, HELOSPECTIN, AND VASOACTIVE INTESTINAL POLYPEPTIDE IN HUMAN CORPUS CAVERNOSUM
    HEDLUND, P
    ALM, P
    EKSTROM, P
    FAHRENKRUG, J
    HANNIBAL, J
    HEDLUND, H
    LARSSON, B
    ANDERSSON, KE
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (04) : 2258 - 2266